Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

Christina S. Gamba, Marcia L. Stefanick, James M. Shikany, Joseph Larson, Eleni Linos, Stacy T. Sims, James Marshall, Linda Van Horn, Nathalie Zeitouni and Jean Y. Tang
Christina S. Gamba
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcia L. Stefanick
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Shikany
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Larson
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleni Linos
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacy T. Sims
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Marshall
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Van Horn
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Zeitouni
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Y. Tang
1Stanford School of Medicine; 2Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford; 3University of California San Francisco School of Medicine, University of California San Francisco, San Francisco, California; 4Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 5WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington; 6Department of Dermatology, Roswell Park Cancer Institute and University of Buffalo, Buffalo, New York; and 7Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0341 Published September 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Large cohort studies have reported no relationship between dietary fat and nonmelanoma skin cancer (NMSC), although a low-fat diet intervention reduced NMSC risk in a small clinical trial. In animal studies, skin tumor development has been reduced by low-fat diet. We evaluated the effect of a low-fat dietary pattern on NMSC and melanoma in the Women's Health Initiative Dietary Modification trial.

Methods: Postmenopausal women aged 50 to 79 years (n = 48,835) were randomly assigned to the low-fat dietary pattern intervention (n = 19,541) or comparison group (n = 29,294). The intervention goals included decreasing fat intake to 20% or less of calories, increasing vegetable and fruit intake, and increasing grain intake. Self-reported incident NMSC (n = 4,907) and physician-adjudicated incident melanoma (n = 279) were ascertained every 6 months.

Results: Over 8.1 years of follow-up, the low-fat diet intervention did not affect overall incidence of NMSC [HR 0.98; 95% confidence interval (CI), 0.92–1.04] or melanoma (HR, 1.04; 95% CI, 0.82–1.32). In subgroup analyses of melanoma risk, baseline fat intake interacted significantly with group assignment (Pinteraction = 0.006). Among women with higher baseline fat intake, the dietary intervention significantly increased risk (HR, 1.48; 95% CI, 1.06–2.07), whereas, among women with lower baseline fat intake, the intervention tended to reduce melanoma risk (HR, 0.72; 95% CI, 0.50–1.02).

Conclusions: In this large randomized trial, a low-fat dietary pattern did not affect overall incidence of NMSC or melanoma.

Impact: A low-fat diet does not reduce incidence of NMSC, but an interaction between baseline fat intake and dietary intervention on melanoma risk warrants further investigation. Cancer Epidemiol Biomarkers Prev; 22(9); 1509–19. ©2013 AACR.

  • Received April 1, 2013.
  • Revision received May 16, 2013.
  • Accepted May 16, 2013.
  • ©2013 American Association for Cancer Research.
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (9)
September 2013
Volume 22, Issue 9
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Christina S. Gamba, Marcia L. Stefanick, James M. Shikany, Joseph Larson, Eleni Linos, Stacy T. Sims, James Marshall, Linda Van Horn, Nathalie Zeitouni and Jean Y. Tang
Cancer Epidemiol Biomarkers Prev September 1 2013 (22) (9) 1509-1519; DOI: 10.1158/1055-9965.EPI-13-0341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Christina S. Gamba, Marcia L. Stefanick, James M. Shikany, Joseph Larson, Eleni Linos, Stacy T. Sims, James Marshall, Linda Van Horn, Nathalie Zeitouni and Jean Y. Tang
Cancer Epidemiol Biomarkers Prev September 1 2013 (22) (9) 1509-1519; DOI: 10.1158/1055-9965.EPI-13-0341
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement